Home People James Kirkpatrick – Biography, Age, Medical Education, Career & Net Worth

James Kirkpatrick – Biography, Age, Medical Education, Career & Net Worth

James Kirkpatrick (born November 1970) is a board-certified American cardiologist in Seattle, Washington. He is the Director of the Echocardiography Lab at the University of Washington Medical Center.

James Kirkpatrick

James Kirkpatrick Facts

  • Full Name: James Neal Kirkpatrick
  • Age: 52years old
  • Date of Birth: November 1970
  • Occupation: Cardiologist
  • Nationality: American

James Kirkpatrick Medical School & Residency

  • University of Chicago Medical Center – Fellowship, Cardiovascular Disease, 2003-2006
  • Yale-New Haven Hospital – Residency, Internal Medicine, 1998-2001
  • Loma Linda University School of Medicine – Medical School

James Kirkpatrick Career

Kirkpatrick is one of the few cardiologists in the United States with ethics training and specializes in ultrasound imaging of left ventricular assist devices.

Certifications & Licensure

  • American Board of Internal Medicine – Certified in Internal Medicine
  • American Board of Internal Medicine – Certified in Cardiovascular Disease
  • IL State Medical License – Active through 2008
  • CA State Medical License – Active through 2016
  • PA State Medical License – Active through
  • WA State Medical License – Active through 2022

Hospital Affiliations

  • UW Medicine-University of Washington Medical Center, Seattle, WA

Specialty Expertise

Dr. James Neal Kirkpatrick has the following 36 areas of expertise

  • Hyperthyroidism
  • Acute Coronary Syndrome (ACS)
  • Hypertension
  • Cardiovascular Disease
  • Thyroid Cancer
  • Endocrinology
  • Left Ventricular Dysfunction
  • Impotence (Vasculogenic Impotence)
  • Arrhythmia
  • Heart Valve Diseases
  • Heart Block
  • Stroke
  • Cardiac Arrhythmias
  • Hypothyroidism
  • Stress Echocardiography
  • Unstable Angina
  • Aortic Aneurysm
  • Atrial Fibrillation
  • Blood Clot
  • Coronary Artery Disease (CAD)
  • High Cholesterol
  • Myocardial Diseases
  • Aortic Diseases
  • Atherosclerosis
  • Heart Attack
  • Percutaneous Arterial Septic Defect (ASD) Closure
  • High Blood Pressure (Hypertension)
  • Diabetes
  • Angina (Angina Pectoris)
  • Heart Failure
  • Heart Disease (Myocardial Ischemia)
  • High Cholesterol (Hypercholesterolemia)
  • Lipid Disorders
  • Osteoporosis
  • Heart Diseases
  • Sinus Arrhythmia

Insurance Accepted

  • Aetna Choice POS II
  • Aetna Managed Choice POS Open Access
  • Aexcel PPO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA LocalPlus
  • CIGNA Open Access Plus
  • CIGNA PPO
  • First Choice
  • First Health PPO
  • Heritage Prime
  • Individual Signature
  • MEDICA CHOICE WITH UNITEDHEALTHC
  • Molina place WA
  • Multiplan PPO
  • Preferred Provider Network – WA
  • Premera Heritage and Heritage Plus 1
  • Premera Heritage Signature
  • UHC Choice Plus POS
  • UHC Nexus Open Access
  • UHC Options PPO
  • UHC Signature Value
  • UW Medicine Accountable Care Network

Location & Contact Information

Heart Institute At University Of Washington Medical Center
1959 NE Pacific St
Seattle, WA 98195
(206) 543-3605

Expert Publications

Data provided by the National Library of Medicine

  • Assessment of global and regional left ventricular diastolic function in hypertensive heart disease using automated border detection techniques.
  • Medical house officers’ attitudes toward vigorous analgesia, terminal sedation, and physician-assisted suicide.
  • Golden rule reasoning in clinical medicine: theoretical and empirical aspects.
  • Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence-assisted border detection.
  • Effects of cardiac resynchronization therapy on ventricular remodeling.
  • Hand-carried echocardiography for assessment of left ventricular filling and ejection fraction in the surgical intensive care unit.
  • Analyzing the “speckled band” to predict response to CRT: a Sherlockian conundrum.
  • Using echo to evaluate patients with left ventricular assist devices (LVADs):
  • Safety and efficacy of pacemaker reuse in underdeveloped nations: a case series.
  • Echocardiographic strain imaging and its use in the clinical setting.
  • Transthoracic and transesophageal echocardiography for the indication of suspected infective endocarditis: vegetations, blood cultures and imaging.
  • Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure.
  • Accuracy of noninvasively determined pulmonary artery systolic pressure.
  • ABCD’s of heart failure: echo-ing through the first stage.
  • Recovery of pacemakers and defibrillators for analysis and device advance directives: electrophysiologists’ perspectives.

James Kirkpatrick Net Worth

James Kirkpatrick has an estimated net worth of $6 million.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.